Phenylephrine (tablet): Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Protected "Phenylephrine (tablet)": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(4 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{DrugProjectFormSinglePage
{{DrugProjectFormSinglePage
|authorTag=
|authorTag={{AV}}
{{AV}}
|OTC=Yes
 
|genericName=phenylephrine hydrochloride tablet
|genericName=phenylephrine hydrochloride tablet
 
|aOrAn=a
 
 
|aOrAn=
 
a
 
|drugClass=[[decongestant]]
|drugClass=[[decongestant]]
 
|indicationType=treatment
 
|indication=nasal congestion due to the [[common cold]], hay fever or other upper respiratory [[allergies]]
|indication=
|adverseReactions=[[pain in eye]], [[nasal congestion]], [[nasal stinging]]/[[burning]], [[sneezing]]<!--Black Box Warning-->
 
|blackBoxWarningTitle=Title
 
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
 
|hasBlackBoxWarning=
 
|adverseReactions=
 
 
 
<!--Black Box Warning-->
 
|blackBoxWarningTitle=
Title
 
|blackBoxWarningBody=
<i><span style="color:#FF0000;">ConditionName: </span></i>


* Content
* Content
Line 37: Line 16:


<!--FDA-Labeled Indications and Dosage (Adult)-->
<!--FDA-Labeled Indications and Dosage (Adult)-->
 
|fdaLIADAdult=*Temporarily relieves nasal congestion due to the [[common cold]], hay fever or other upper respiratory [[allergies]]
|fdaLIADAdult=
 
*Temporarily relieves nasal congestion due to the [[common cold]], hay fever or other upper respiratory [[allergies]]
*Temporarily relieves [[sinus congestion]] and pressure
*Temporarily relieves [[sinus congestion]] and pressure
* Dosing Information
* Dosing Information


: [[File:{{PAGENAME}}02.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
: [[File:{{PAGENAME}}02.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]


<!--Off-Label Use and Dosage (Adult)-->
<!--Off-Label Use and Dosage (Adult)-->


<!--Guideline-Supported Use (Adult)-->
<!--Guideline-Supported Use (Adult)-->
 
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultGuideSupport=
 
 
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Non–Guideline-Supported Use (Adult)-->
<!--Non–Guideline-Supported Use (Adult)-->
 
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultNoGuideSupport=
 
 
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Pediatric Indications and Dosage-->
<!--Pediatric Indications and Dosage-->


<!--FDA-Labeled Indications and Dosage (Pediatric)-->
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
 
|fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
|fdaLIADPed=
 
 
 
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.


<!--Off-Label Use and Dosage (Pediatric)-->
<!--Off-Label Use and Dosage (Pediatric)-->


<!--Guideline-Supported Use (Pediatric)-->
<!--Guideline-Supported Use (Pediatric)-->
 
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedGuideSupport=
 
 
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Non–Guideline-Supported Use (Pediatric)-->
<!--Non–Guideline-Supported Use (Pediatric)-->
 
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedNoGuideSupport=
 
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Contraindications-->
<!--Contraindications-->
 
|contraindications=<!--Warnings-->
|contraindications=
|warnings=* Do not use
 
<!--Warnings-->
 
|warnings=
 
* Do not use


:*if you are now taking a prescription [[monoamine oxidase inhibitor]] (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or [[Parkinson’s disease]]), or for 2 weeks after stopping the [[MAOI]] drug. If you do not know if your prescription drug contains an [[MAOI]], ask a doctor or pharmacist before taking this product.
:*if you are now taking a prescription [[monoamine oxidase inhibitor]] (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or [[Parkinson’s disease]]), or for 2 weeks after stopping the [[MAOI]] drug. If you do not know if your prescription drug contains an [[MAOI]], ask a doctor or pharmacist before taking this product.
Line 119: Line 65:


<!--Clinical Trials Experience-->
<!--Clinical Trials Experience-->
 
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|clinicalTrials=
 
There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.






<!--Postmarketing Experience-->
<!--Postmarketing Experience-->
 
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=
 
There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.






<!--Drug Interactions-->
<!--Drug Interactions-->
 
|drugInteractions=<!--Use in Specific Populations-->
|drugInteractions=
|FDAPregCat=C
 
|useInPregnancyFDA=* ask a health professional before use.
 
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
 
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
<!--Use in Specific Populations-->
|useInPed=*Keep out of reach of children.
 
|useInPregnancyFDA=
* ask a health professional before use.
 
|useInPregnancyAUS=
|useInLaborDelivery=
There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
 
|useInNursing=
There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
 
|useInPed=
*Keep out of reach of children.


:*In case of overdose, get medical help or contact a Poison Control Center right away.
:*In case of overdose, get medical help or contact a Poison Control Center right away.
|useInGeri=
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
 
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
 
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with [[renal impairment]].
|useInGender=
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with [[hepatic impairment]].
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
 
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are [[immunocompromised]].
|useInRace=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
 
|useInRenalImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
 
|useInHepaticImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
 
|useInReproPotential=
There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
 
|useInImmunocomp=
There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.


<!--Administration and Monitoring-->
<!--Administration and Monitoring-->
 
|administration=* Oral
|administration=
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
 
* Oral
 
 
|monitoring=
 
There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.






<!--IV Compatibility-->
<!--IV Compatibility-->
 
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|IVCompat=
 
There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.


<!--Overdosage-->
<!--Overdosage-->
 
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
|overdose=
 
 
 
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.


<!--Pharmacology-->
<!--Pharmacology-->


<!--Drug box 2-->
<!--Drug box 2-->
|drugBox={{Drugbox2
| Watchedfields = changed
|verifiedrevid=464201108
|IUPAC_name=(''R'')-3-[-1-hydroxy-2-(methylamino)ethyl]phenol
|image=Phenylephrine00.png
|image2=phenylephrine000.png
<!--Clinical data-->
|Drugs.com={{drugs.com|monograph|phenylephrine-hydrochloride}}
|MedlinePlus=a606008
|pregnancy_AU=B2
|pregnancy_US=C
|legal_UK=GSL
|legal_US=OTC
|routes_of_administration=Oral, intranasal, ophthalmic, intravenous, intramuscular
<!--Pharmacokinetic data-->
|bioavailability=38% through GI tract
|protein_bound=95%
|metabolism=[[Liver|Hepatic]] ([[monoamine oxidase]])
|elimination_half-life={{nowrap|2.1–3.4 h}}
<!--Identifiers-->
|CASNo_Ref={{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
|CAS_number=59-42-7
|CAS_supplemental=<br /> {{CAS|61-76-7}} ([[hydrochloride]]) <!-- Also CAS verified -->
|ATC_prefix=C01
|ATC_suffix=CA06
|ATC_supplemental={{ATC|R01|AA04}}, {{ATC|R01|AB01}} (combinations), {{ATC|R01|BA03}}, {{ATC|S01|FB01}}, {{ATC|S01|GA05}}
|PubChem=6041
|IUPHAR_ligand=485
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
|DrugBank=DB00388
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
|ChemSpiderID=5818
| UNII_Ref = {{fdacite|correct|FDA}}
|UNII=1WS297W6MV
| KEGG_Ref = {{keggcite|correct|kegg}}
|KEGG=D08365
| ChEBI_Ref = {{ebicite|correct|EBI}}
|ChEBI=8093
| ChEMBL_Ref = {{ebicite|correct|EBI}}
|ChEMBL=1215


|drugBox=
<!--Chemical data-->
 
|C=9|H=13|N=1|O=2
 
|molecular_weight=167.205 g/mol
 
|smiles=O[C@H](c1cc(O)ccc1)CNC
<!--Mechanism of Action-->
|InChI=1/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1
 
|InChIKey=SONNWYBIRXJNDC-VIFPVBQEBB
|mechAction=
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
 
|StdInChI=1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1
<!--Structure-->
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
 
|StdInChIKey=SONNWYBIRXJNDC-VIFPVBQESA-N
|structure=
}}<!--Mechanism of Action-->
 
|mechAction=<!--Structure-->
 
|structure=<!--Pharmacodynamics-->
<!--Pharmacodynamics-->
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
 
|PD=
 
There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.


<!--Pharmacokinetics-->
<!--Pharmacokinetics-->
 
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
|PK=
 
There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.


<!--Nonclinical Toxicology-->
<!--Nonclinical Toxicology-->
 
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
|nonClinToxic=
 
There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.


<!--Clinical Studies-->
<!--Clinical Studies-->
 
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
|clinicalStudies=
 
There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.


<!--How Supplied-->
<!--How Supplied-->
 
|howSupplied=* store at 20º-25ºC (68º-77ºF)
|howSupplied=
 
* store at 20º-25ºC (68º-77ºF)
<!--Patient Counseling Information-->
<!--Patient Counseling Information-->
 
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|fdaPatientInfo=
 
There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.


<!--Precautions with Alcohol-->
<!--Precautions with Alcohol-->
 
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
|alcohol=
 
* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.


<!--Brand Names-->
<!--Brand Names-->
 
|brandNames=* Equate
|brandNames=
 
* Equate


<!--Look-Alike Drug Names-->
<!--Look-Alike Drug Names-->
 
|lookAlike=<!--Drug Shortage Status-->
|lookAlike=
 
 
 
<!--Drug Shortage Status-->
 
|drugShortage=
|drugShortage=
}}
}}
<!--Pill Image-->
<!--Pill Image-->


Latest revision as of 16:56, 20 August 2015

Phenylephrine (tablet)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Phenylephrine (tablet) is a decongestant that is FDA approved for the treatment of nasal congestion due to the common cold, hay fever or other upper respiratory allergies. Common adverse reactions include pain in eye, nasal congestion, nasal stinging/burning, sneezing.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

This image is provided by the National Library of Medicine.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Phenylephrine (tablet) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Phenylephrine (tablet) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Phenylephrine (tablet) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Phenylephrine (tablet) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Phenylephrine (tablet) in pediatric patients.

Contraindications

There is limited information regarding Phenylephrine (tablet) Contraindications in the drug label.

Warnings

  • Do not use
  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
  • Ask a doctor before use if you have
  • When using this product
  • do not use more than directed

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Phenylephrine (tablet) in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Phenylephrine (tablet) in the drug label.

Drug Interactions

There is limited information regarding Phenylephrine (tablet) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): C

  • ask a health professional before use.


Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Phenylephrine (tablet) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Phenylephrine (tablet) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Phenylephrine (tablet) with respect to nursing mothers.

Pediatric Use

  • Keep out of reach of children.
  • In case of overdose, get medical help or contact a Poison Control Center right away.

Geriatic Use

There is no FDA guidance on the use of Phenylephrine (tablet) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Phenylephrine (tablet) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Phenylephrine (tablet) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Phenylephrine (tablet) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Phenylephrine (tablet) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Phenylephrine (tablet) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Phenylephrine (tablet) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral

Monitoring

There is limited information regarding Monitoring of Phenylephrine (tablet) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Phenylephrine (tablet) in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Phenylephrine (tablet) in the drug label.

Pharmacology

Template:Px
Template:Px
Phenylephrine (tablet)
Systematic (IUPAC) name
(R)-3-[-1-hydroxy-2-(methylamino)ethyl]phenol
Identifiers
CAS number 59-42-7

61-76-7 (hydrochloride)
ATC code C01CA06 R01AA04 (WHO), R01AB01 (WHO) (combinations), R01BA03 (WHO), S01FB01 (WHO), S01GA05 (WHO)
PubChem 6041
DrugBank DB00388
Chemical data
Formula Template:OrganicBox atomTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox 
Mol. mass 167.205 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability 38% through GI tract
Protein binding 95%
Metabolism Hepatic (monoamine oxidase)
Half life 2.1–3.4 h
Excretion ?
Therapeutic considerations
Pregnancy cat.

B2(AU) C(US)

Legal status

GSL(UK) OTC(US)

Routes Oral, intranasal, ophthalmic, intravenous, intramuscular

Mechanism of Action

There is limited information regarding Phenylephrine (tablet) Mechanism of Action in the drug label.

Structure

There is limited information regarding Phenylephrine (tablet) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Phenylephrine (tablet) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Phenylephrine (tablet) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Phenylephrine (tablet) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Phenylephrine (tablet) in the drug label.

How Supplied

  • store at 20º-25ºC (68º-77ºF)

Storage

There is limited information regarding Phenylephrine (tablet) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Phenylephrine (tablet) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Phenylephrine (tablet) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Phenylephrine (tablet) in the drug label.

Precautions with Alcohol

  • Alcohol-Phenylephrine (tablet) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

  • Equate

Look-Alike Drug Names

There is limited information regarding Phenylephrine (tablet) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.


{{#subobject: 

 |Label Page=Phenylephrine (tablet)
 |Label Name=Phenylephrine (tablet)03.png

}}


{{#subobject: 

 |Label Page=Phenylephrine (tablet)
 |Label Name=Phenylephrine (tablet)04.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Phenylephrine_(tablet)&oldid=1137257"